Grant of Options under Company EMI Plan

RNS Number : 7933A

Omega Diagnostics Group PLC

24 January 2020

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Grant of Options under Company EMI Plan

Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing, announces that certain Directors and PDMRs were granted options on 23 January 2020 (the "Grant Date") to subscribe for an aggregate of 3,150,000 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") at an exercise price of 15.4 pence per Ordinary Share (the "Options"). The Options are being granted under the Company's 2020 EMI Plan. The Options shall have a two-year vesting period, after which the Option may then be exercised in whole or in part in accordance with the Rules of the Plan.

A full break down of Directors and PDMRs being granted the Options is provided below:

Name	Director or PDMR	Current Options	Proposed Option award	Total Options after award
Colin King	Chief Executive Officer	1,200,000	950,000	2,150,000
Kieron Harbinson	Group Finance Director	940,000	750,000	1,690,000
Jag Grewal	Group Commercial Director	910,000	500,000	1,410,000
Edward Valente	PDMR	300,000	100,000	400,000
Mike Gordon	PDMR	290,000	100,000	390,000
Jamie Yexley	PDMR	225,000	100,000	325,000
Patrick Breen	PDMR	45,000	150,000	195,000
Angela Robertson	PDMR	25,000	100,000	125,000
John Bannister	PDMR	230,000	100,000	330,000
Derek Brady	PDMR	0	150,000	150,000
Jill Hepburn	PDMR	0	150,000	150,000
Total		4,165,000	3,150,000	7,315,000

The Options issued to Colin King, Kieron Harbinson and Jag Grewal contain an additional performance condition which states the Option shall not be capable of being exercised unless and until the middle-market quotation of a Share is equal or greater than 30p at any time on or after the second anniversary of the Grant Date, after which the Option may then be exercised in whole or in part in accordance with the Rules of the Plan as if no further Performance Condition applied.

Following the Option award, there are a total of 13,645,406 unexercised options over Ordinary Shares in the Company, representing 9.07 per cent. of the issued share capital.

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

Contacts: 

Omega Diagnostics Group PLC	Tel: [phone]
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: [phone]
Geoff Nash/Hannah Boros (Corporate Finance)
Camille Gochez (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Kieron Harbinson
2	Reason for the notification
a)	Position / status	Group Finance Director
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 750,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Colin King
2	Reason for the notification
a)	Position / status	CEO
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 950,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jag Grewal
2	Reason for the notification
a)	Position / status	Group Commercial Director
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 500,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Edward Valente
2	Reason for the notification
a)	Position / status	PDMR
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 100,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mike Gordon
2	Reason for the notification
a)	Position / status	PDMR
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 100,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jamie Yexley
2	Reason for the notification
a)	Position / status	PDMR
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 100,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Patrick Breen
2	Reason for the notification
a)	Position / status	PDMR
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 150,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Angela Robertson
2	Reason for the notification
a)	Position / status	PDMR
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 100,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	John Bannister
2	Reason for the notification
a)	Position / status	PDMR
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 100,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Derek Brady
2	Reason for the notification
a)	Position / status	PDMR
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 150,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jill Hepburn
2	Reason for the notification
a)	Position / status	PDMR
	Initial notification / amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 4p each ("Ordinary Shares")
	Identification code	ISIN:  GB00B1VCP282
b)	Nature of transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 150,000
d)	Aggregated information	As above
e)	Date of the transaction	23 January 2020
f)	Place of the transaction	N/a

 

END

 

 

DSHEAEFDADFEEAA